Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3339

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Atorvastatin Calcium 20 mg film-coated tablet label showing quantity of 30 tablets. The label includes the NDC number 70518-3339-00, repackaging information by RemedyRepack Inc., and the original manufacturer Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label has instructions to see the package insert for directions and storage conditions from 20-25°C with excursions permitted to 15-30°C.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

A cumulative incidence line graph comparing Atorvastatin with placebo over time in years. The solid line represents Atorvastatin, and the dashed line represents placebo, showing lower cumulative incidence for Atorvastatin. The graph includes a hazard ratio (HR=0.64) with 95% confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

A line graph depicting cumulative hazard percentage over time to first primary endpoint through four years of follow-up. It compares two groups: Placebo (dashed line) and Atorvastatin (solid line). The Atorvastatin group shows a lower cumulative hazard than the Placebo group, with a hazard ratio of 0.63 (0.48-0.83) and p-value of 0.001.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

A line chart comparing the percentage of subjects experiencing a major cardiovascular event over 5 years for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The 10 mg dosage is represented by a dashed line, and the 80 mg dosage by a solid line, with hazard ratio and p-value indicated.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of Atorvastatin calcium, illustrating the molecular components including phenyl groups, hydroxyl groups, carboxyl groups, calcium ion, and associated water molecules (3H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.